Select your country
Select a country to go to the website of the respective STADA sales company.
Saudi Arabia (1)
The Phillippines (1)
United Arab Emirates (1)
In addition to supplying a wide range of generic medicines to treat conditions within the central nervous system generic medicines, STADA has an extensive heritage in offering proprietary, differentiated treatment options in neurology, especially for late-stage Parkinson’s disease through its Britannia Pharmaceuticals subsidiary. For more than 30 years, Britannia has been developing innovative, patient-centric technologies that deliver effective treatment for to people living with Parkinson’s disease worldwide.
Through the dedicated commercial infrastructure offered by Britannia, STADA is able to expand therapeutic options and improve access to effective treatments for Parkinson’s disease, movement disorders and other life-altering neurological conditions.